Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (16)

1999

  1. Scaleup of a pharmaceutical granulation in planetary mixers

    Pharmaceutical Development and Technology, Vol. 4, Núm. 2, pp. 145-150

1996

  1. A comparison of the wet massing properties of high- and low-density microcrystalline cellulose

    Pharmaceutical Sciences, Vol. 2, Núm. 3, pp. 125-126

  2. Scale-up of a pharmaceutical granulation in fixed bowl mixer-granulators

    International Journal of Pharmaceutics, Vol. 133, Núm. 1-2, pp. 127-131

  3. The effect of batch size on scale-up of a pharmaceutical granulation in a fixed bowl mixer granulator

    International Journal of Pharmaceutics, Vol. 134, Núm. 1-2, pp. 243-246

1994

  1. Chemical stability of acetylsalicylic acid in tablets prepared with different commercial brands of dicalcium phosphate dihydrate

    International Journal of Pharmaceutics, Vol. 107, Núm. 3, pp. 247-249

  2. Dicalcium phosphate dihydrate for direct compression: Characterization and intermanufacturer variability

    International Journal of Pharmaceutics, Vol. 109, Núm. 1, pp. 1-8

  3. Particle size effects on the dehydration of dicalcium phosphate dihydrate powders

    International Journal of Pharmaceutics, Vol. 104, Núm. 3, pp. 271-275

  4. Structural changes during the dehydration of dicalcium phosphate dihydrate

    European Journal of Pharmaceutical Sciences, Vol. 2, Núm. 3, pp. 245-252

  5. The effect of country of origin on the properties of dicalcium phosphate dihydrate powder

    International Journal of Pharmaceutics, Vol. 103, Núm. 1, pp. 9-18

1993

  1. Interlot variability of carbomer 934

    International Journal of Pharmaceutics, Vol. 100, Núm. 1-3, pp. 207-212

  2. PARTICLE SIZE EFFECTS ON THE DEHYDRATION OF DICALCIUM PHOSPHATE DIHYDRATE

    Pharmacy and Pharmacology Communications, Vol. 45, Núm. 12 S, pp. 1137-1137